走进鲁银
  鲁银标识
  企业概况
  企业历程
  企业荣誉
  所处位置: 详细信息
     
 
奥勃兰参考文献

录入时间:2012-12-29 16:58:10   点击次数:8381  
【英文文献】
[1] Tárnok K, Kiss E, Luiten PG, Nyakas C, Tihanyi K, Schlett K, Eisel UL. Effects of Vinpocetine on mitochondrial function and   neuroprotection in primary cortical neurons. Neurochem Int. 2008 Dec;53(6-8):289-95. Epub 2008 Aug 28.
[2] Vas A, Shchukin Y, Karrenbauer VD, Cselényi Z, Kostulas K, Hillert J, Savic I, Takano A, Halldin C, Gulyás B. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients. J Neurol Sci. 2008 Jan 15;264(1-2):9-17. Epub 2007 Aug 28.
[3] Lendvai B, Zelles T, Rozsa B, Vizi ES. A vinca alkaloid enhances morphological dynamics of dendritic spines of neocortical layer 2/3 pyramidal cells. Brain Res Bull. 2003 Jan 15;59(4):257-60.
[4] Jucker M, Bättig K, Meier-Ruge W. Effects of aging and vincamine derivatives on pericapillary microenvironment: stereological characterization of the cerebral capillary network. Neurobiol Aging. 1990 Jan-Feb;11(1):39-46.
[5] Jucker M, Meier-Ruge W. Effects of brovincamine on stereological capillary parameters in adult and old Fischer-344 rats. Microvasc Res. 1989 May;37(3):298-307.
[6] Juan YP, Tsai TH. Measurement and pharmacokinetics of vincamine in rat blood and brain using microdialysis. J Chromatogr A. 2005 Sep 23;1088(1-2):146-51.
[7] Hagstadius S, Gustafson L, Risberg J.The effects of bromvincamine and vincamine on regional cerebral blood flow and mental functions in patients with multi-infarct dementia. Psychopharmacology (Berl). 1984;83(4):321-6.
[8] Fischhof PK, Möslinger-Gehmayr R, Herrmann WM, Friedmann A, Russmann DL.Therapeutic efficacy of vincamine in dementia. Neuropsychobiology. 1996;34(1):29-35.
[9] Fayed AH. Brain trace element concentration of rats treated with the plant alkaloid, vincamine. Biol Trace Elem Res. 2010 Sep;136(3):314-9. Epub 2009 Nov 10.
[10] Vas A, Gulyás B. Eburnamine derivatives and the brain. Med Res Rev. 2005 Nov;25(6):737-57.
[11] Ilkay Orhan, Qamar Naz,Murat Kartal, Fatma Tosum, Bilge Sener, and M.Iqbal Choudhary. In vitro Anticholinesterase Activity of Various Alkaloids. Z. Naturforsch,62c,684-688(2007).
[12] Juan YP, Tsai TH. Measurement and pharmacokinetics of vincamine in rat blood and brain using microdialysis. J Chromatogr A. 2005 Sep 23;1088(1-2):146-51.
[13] Vereczkey L, Tamas G, Szporny L. Metabolism of vincamine in the rat in vivo and in vitro. Drug Res. 30(11). Nr.11(1980)
[14] Martucci N, Manna V, Agnoli A. Pharmaco-EEG study on vincamine and on teproside in patients with chronic cerebrovascular disease. Int J Clin Pharmacol Res. 1984;4(4):291-302.
[15] Vereczkey L. Pharmacokinetics and metabolism of vincamine and related compounds. Eur J Drug Metab Pharmacokinet. 1985 Apr-Jun;10(2):89-103.
[16] Koseki N, Araie M, Yamagami J, Shirato S, Yamamoto S.Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure. J Glaucoma. 1999 Apr;8(2):117-23.
[17] Sawada A, Kitazawa Y, Yamamoto T, Okabe I, Ichien K. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology. 1996 Feb;103(2):283-8.
[18] Erdo SA, Molnár P, Lakics V, Bence JZ, Tömösközi Z. Vincamine and vincanol are potent blockers of voltage-gated Na+ channels. Eur J Pharmacol. 1996 Oct 24;314(1-2):69-73.
[19] Gulyás B, Halldin C, Vas A, Banati RB, Shchukin E, Finnema S, Tarkainen J, Tihanyi K, Szilágyi G, Farde L. [11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies. J Neurol Sci. 2005 Mar 15;229-230:219-23. Epub 2004 Dec 16.
【中文文献】
[1] 郭梅,徐一峰. 阿朴长春胺酸乙酯治疗Alzheimer型痴呆和多发梗塞性痴呆及血流变学分析. 上海医科大学学报. 1995 5(22): 391-393.
[2] 于群涛,于天霞,王英等.奥勃兰治疗慢性缺血性脑血管病的临床观察[J].实用心脑肺血管病杂志,2004,12(6):333-334,332.
[3]曾存芝,周增杰.奥勃兰治疗脑梗死100例临床观察[J].实用中医药杂志,2004,20(11):646-647.
[4] 罗四维,李东升.奥勃兰治疗主观性耳鸣的临床观察[J].听力学及言语疾病杂志,2010,18(6):601-602.
[5] 迟海涛,金蕊.长春胺缓释胶囊治疗血管性认知功能障碍:与尼莫地平的对照[J].中国组织工程研究与临床康复,2009,13(47):9369-9372.
[6] 匡良洪,肖胜,肖劲松等.长春胺缓释胶囊对卒中后抑郁和神经功能恢复的作用观察[J].中国基层医药,2011,18(18):2471-2473.
[7] 马文娟.长春胺缓释胶囊治疗53例慢性脑供血不足的疗效观察[J].中国民康医学,2011,23(3):297-327.
[8] 刘艳,张倩,黄丹琳等.长春胺对原发性缺血性视神经视网膜脉络膜病变疗效观察[J].临床军医杂志,2008,36(2):231-232.
[9] 侯恩太,李多伟.小蔓长春花中长春胺药学研究进展[J].西北药学杂志,2010,25(4):314-316.
[10] 段炼,潘爱萍.长春胺治疗老年痴呆症的临床观察和疗效[J].陕西中医学院学报,2005,28(5):19-20.
[11] 李敏,张广东,黄卫华等.长春胺治疗脑梗死患者运动及认知功能的临床研究[J].中原医刊,2007,34(9):43-44.
[12] 安丽荣,孙超,魏广宽等.舒血宁联用长春胺治疗椎基动脉系统供血不全40例疗效观察[J].黑龙江医学,2012,36(4):282-283,311.
[13] 张倩,刘艳,夏江南等.复方樟柳碱联合长春胺治疗原发性缺血性视神经视网膜脉络膜病变疗效观察[J].医学新知杂志,2012,22(1):34-35.
[14] 邢蕾,于春侠,于华,刁文杰,张杰. 小蔓长春花生物碱长春胺治疗缺血性脑血管疾病的研究进展回顾. 上海中医药杂志,2013年,第5期
[15] 任骞,张杰. 小蔓长春花生物碱长春胺及其类似物药理作用机制研究进展. 中草药,2013年,已录用
 
   
 
版权所有:烟台鲁银药业有限公司   制作维护:烟台一搜